Zylox-Tonbridge Medical Technology Co., Ltd. (HKG:2190)

Market Cap	6.66B
Revenue (ttm)	832.69M
Net Income (ttm)	106.69M
Shares Out	320.27M
EPS (ttm)	0.33
PE Ratio	63.94
Forward PE	34.20
Dividend	0.11 (0.52%)
Ex-Dividend Date	Jun 4, 2025

Volume	440,528
Average Volume	614,085
Open	20.70
Previous Close	20.65
Day's Range	20.25 - 21.15
52-Week Range	9.41 - 22.00
Beta	0.51
RSI	62.86
Earnings Date	Aug 15, 2025

About HKG:2190

Zylox-Tonbridge Medical Technology Co., Ltd., a medical device company, provides neuro- and peripheral-vascular interventional medical devices in the People’s Republic of China and internationally. The company offers a neurovascular product portfolio that covers a suite of products for various categories, including ischemic stroke, hemorrhagic stroke, intracranial stenosis, carotid artery, and intracranial access devices. Its peripheral-vascular interventional product portfolio includes stents, balloons, catheters, and filters, as well as cover...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2012
• Employees: 875
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 2190

Financial Performance

Financial numbers in CNY